Stanford Marianne M, Werden Steven J, McFadden Grant
Biotherapeutics Research Group, Robarts Research Institute, University of Western Ontario, Siebens-Drake Building, Room 126, 1400 Western Road, London, Ontario, N6G 2V4, Canada.
Vet Res. 2007 Mar-Apr;38(2):299-318. doi: 10.1051/vetres:2006054. Epub 2007 Feb 13.
Myxoma virus (MV) is a poxvirus that evolved in Sylvilagus lagomorphs, and is the causative agent of myxomatosis in European rabbits (Oryctolagus cuniculus). This virus is not a natural pathogen of O. cuniculus, yet is able to subvert the host rabbit immune system defenses and cause a highly lethal systemic infection. The interaction of MV proteins and the rabbit immune system has been an ideal model to help elucidate host/poxvirus interactions, and has led to a greater understanding of how other poxvirus pathogens are able to cause disease in their respective hosts. This review will examine how MV causes myxomatosis, by examining a selection of the identified immunomodulatory proteins that this virus expresses to subvert the immune and inflammatory pathways of infected rabbit hosts.
黏液瘤病毒(MV)是一种在棉尾兔属兔科动物中进化而来的痘病毒,是欧洲兔(穴兔)黏液瘤病的病原体。这种病毒并非穴兔的天然病原体,但它能够破坏宿主兔的免疫系统防御,引发高度致命的全身性感染。MV蛋白与兔免疫系统的相互作用一直是帮助阐明宿主/痘病毒相互作用的理想模型,并使人们对其他痘病毒病原体如何在各自宿主中致病有了更深入的了解。本综述将通过研究该病毒表达的一系列已确定的免疫调节蛋白来探讨MV如何引发黏液瘤病,这些蛋白可破坏受感染兔宿主的免疫和炎症途径。